What is the ticker symbol for Hillstream BioPharma?

Hillstream BioPharma trades under the ticker HILS on NASDAQ.

What sector does Hillstream BioPharma operate in?

Hillstream BioPharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze HILS in a portfolio?

PortView shows HILS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Hillstream BioPharma (HILS) Stock Analysis

NASDAQHealthcareBiotechnology

$0.24+5.66%

1-year price historyRange $0.18 – $1.89

52-week range$0.24

$0.17$2.65

What Hillstream BioPharma does

Hillstream BioPharma, Inc. is a pre-clinical stage biotechnology firm committed to creating groundbreaking therapeutic options. Its core mission is to exploit ferroptosis, an anti-cancer pathway that initiates iron-mediated cell death (IMCD), specifically to address cancers that are resistant to conventional treatments. The company's developmental pipeline features several key candidates: HSB-1216: An IMCD inducer currently under development for solid tumor indications. HSB-888: An IMCD inducer incorporating an anthracycline analogue, delivered via a dual Quatramer system, also aimed at solid tumors. HSB-510: A targeted bifunctional inhibitory compound, encapsulated within the Quatramer delivery system, which demonstrates remarkable potency (single-digit nanomolar IC50) against both PI3K-delta and HDAC6, targets recognized for their role in downregulating cellular processes. HSB-114: An immunotherapeutic agent that leverages the proprietary Quatramer technology to precisely deliver the tumor necrosis factor-alpha gene into cancer cells. Established in 2017, the company's operations are based in Bridgewater, New Jersey.

Key metrics

Market cap

$4.17M

P/E (TTM)

-0.34

EPS (TTM)

$-0.70

Beta

0.00

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$0.25

200-day avg

$0.58

52-week high

$2.65

52-week low

$0.17

CEO

Randy D. Milby MBA

ETFs linked to HILS

Broad-market and Healthcare sector ETFs an investor holding Hillstream BioPharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how HILS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HILS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Hillstream BioPharma?: Hillstream BioPharma trades under the ticker HILS on NASDAQ.
Which exchange is HILS listed on?: HILS is listed on NASDAQ.
What sector does Hillstream BioPharma operate in?: Hillstream BioPharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze HILS in a portfolio?: PortView shows HILS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.